About ABL Biotechnologies
ABL Biotechnologies is a Healthcare company based in Chennai (India) founded in 1992. Biochemicals from marine microbes for the application in pharmaceuticals, nutritional, and cosmetic industries. Its chief executive, as recorded, is Kollenmareth Oomman Isaac. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Glycobiology. Its legal entity in India is Abl Bio-technologies Limited (L52599TN1992PLC022340). Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
ABL Biotechnologies (ABL) is focused on the identification extraction of biochemicals from microbes for the application in pharmaceuticals, nutritional, and cosmetic industries. It also has a microbial metabolites laboratory identifying biochemicals from marine organisms. The company offers products, beta-carotene, Lycopene, and Lutein. Also, focused on contract manufacturing of finish dosage forms including soft and hard gelatine capsules, tablets, liquid orals, and topical ointments, sterile injectables and lyophilized products. The company has manufacturing sites in India, Malaysia, and Singapore. These facilities manufacture biopharmaceutical bulk recombinant formulations. The company is conducting research on polysaccharides, Docosahexaenoic acid (DHA), natural pigments, tracers, and tags.
- Headquarters Chennai, India
- SectorsHealthcare
- Phone•••• ••••
- Website ablbiotechnologies.com
- Legal Name Abl Bio-Technologies Limited
- Date of Incorporation 16 Mar, 1992
- Jurisdiction Chennai, Tamil Nadu, India
Associated legal entities of ABL Biotechnologies
ABL Biotechnologies operates through Abl Bio-Technologies Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abl Bio-Technologies Limited Listed CIN L52599TN1992PLC022340 | Active | 16 Mar 1992 | Chennai, Tamil Nadu | 3 | View details |
Board of directors of Abl Bio-Technologies Limited (ABL Biotechnologies)
Abl Bio-Technologies Limited is the primary company behind ABL Biotechnologies. The board of Abl Bio-Technologies Limited currently have 3 directors; the longest-serving is Kollenmareth Oomman Isaac, appointed in 1992. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kollenmareth Oomman Isaac DIN 01421392 | Managing Director | 16 Mar 1992 | 34 yrs 7 mo | Abl Bio-Technologies Limited |
| Subramanian Gopalakrishnan DIN 00064138 | Director | 30 Oct 2003 | 23 yrs | Abl Bio-Technologies Limited |
| Sankaran Nampoothiri Velliyod Madhavan DIN 01485826 | Director | 13 Dec 2008 | 17 yrs 10 mo | Abl Bio-Technologies Limited |
People of ABL Biotechnologies
1 people are tracked at ABL Biotechnologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for ABL Biotechnologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to ABL Biotechnologies
ABL Biotechnologies has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of ABL Biotechnologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abl Biotechnologies
Complete news archive for ABL Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABL Biotechnologies
ABL Biotechnologies was founded in 1992.
ABL Biotechnologies is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Kollenmareth Oomman Isaac is the CEO of ABL Biotechnologies, as recorded in our data.
ABL Biotechnologies (ABL) is focused on the identification extraction of biochemicals from microbes for the application in pharmaceuticals, nutritional, and cosmetic industries. It also has a microbial metabolites laboratory identifying biochemicals from marine organisms. The company offers products, beta-carotene, Lycopene, and Lutein. Also, focused on contract manufacturing of finish dosage forms including soft and hard gelatine capsules, tablets, liquid orals, and topical ointments, sterile injectables and lyophilized products. The company has manufacturing sites in India, Malaysia, and Singapore. These facilities manufacture biopharmaceutical bulk recombinant formulations. The company is conducting research on polysaccharides, Docosahexaenoic acid (DHA), natural pigments, tracers, and tags.
ABL Biotechnologies's top competitors include Laurus Labs, Symbiotec and SeQuent.
ABL Biotechnologies operates through Abl Bio-Technologies Limited.
The legal entities of ABL Biotechnologies currently have 3 directors, including Subramanian Gopalakrishnan, Kollenmareth Oomman Isaac, Sankaran Nampoothiri Velliyod Madhavan.